News Oligomerix Appoints William Erhardt, M.D., as Chief Medical Officer May 20, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix to Present at AAIC 2020 Conference on Small Molecule Inhibitor of Tau Self-AssociationNext →Oligomerix Announces Appointment of Robert Foerster, Former Pfizer Executive, as Chief Financial Officer
